Eileen Tzng

Eileen Tzng

Auto-generated profile, based on publicly available information

Eileen Tzng

Stanford Cardiovascular Institute

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2023 in Extracellular Vesicle
Verified
Journal Article
Open access
ETEileen Tzng
Eileen Tzng
NBNathan Bayardo
Nathan Bayardo
PYPhillip Yang
Phillip Yang
Cardiovascular disease is the leading cause of death worldwide today and numerous studies are demonstrating that exosomes improve cardiac function after myocardial injury through various mechanisms. Exosome therapy has great potential as an effective precision medicine biologic by targeting the underlying disease process. However, this innovative approach may face some challenges, such as zeta potential, standardization of exosome collection, biopharmaceutical regulation, and more importantly, specific clinical application of exosome therapy. These issues will be addressed by broadly summarizing the biological plausibility; delivery, dosing, and pharmacokinetics; and reproducibility and manufacturing with a focus on microRNA as molecular cargo.

4 November 2025 in Journal of the American Heart Association
Verified
Journal Article
Open access
ETEileen Tzng
Eileen Tzng
NBNathan Bayardo
Nathan Bayardo
GIGentaro Ikeda
Gentaro Ikeda
NVNirmal Vadgama
Nirmal Vadgama
HTHiroyuki Takashima
Hiroyuki Takashima
PYPhillip Yang
Phillip Yang
Background: Exosomes are extracellular vesicles 30 to 150 nm in size, mediating the paracrine effects of mesenchymal stem cells (MSCs) and induced pluripotent stem cell–derived cardiomyocytes (iCMs) when used to restore the injured myocardium. While both MSC‐ and iCM‐derived exosomes (MSC‐Exo, iCM‐Exo) improve cardiac function, their mechanisms of action remain incompletely understood. This study investigates the shared and distinct effects of iCM‐Exo and MSC‐Exo in a porcine ischemia–reperfusion injury model. Methods: Female Yorkshire swine underwent proximal left anterior descending artery occlusion with a catheter balloon to induce ischemia–reperfusion injury. Ten 500‐μL transendocardial injections delivered a total of 5×10 11 iCM‐Exo or MSC‐Exo into the peri‐infarct region. Cardiac function was assessed via MRI at weeks 2 and 4, while transcriptomic sequencing of peri‐infarct tissue alongside exosomal cargo were performed to elucidate molecular drivers of exosome influenced, post ischemic modulation of gene expression. Results: Cardiac MRI revealed that iCM‐Exo significantly improved left ventricular ejection fraction, myocardial viability, scar size, and ventricular remodeling compared with MSC‐Exo and PBS controls. Transcriptomic analysis revealed both shared and distinct gene expression patterns between the treatments. Shared pathways, including extracellular matrix remodeling and neurovascular integration, contributed to baseline cardiac improvement. Distinct pathways in iCM‐Exo treatment involved metabolic reorganization and cardiomyocyte‐specific processes, while MSC‐Exo emphasized structural stabilization and anti‐inflammatory responses. Conclusions: These findings highlight the complementary roles of iCM‐Exo and MSC‐Exo in myocardial repair with shared pathways contributing to baseline improvement and distinct pathways driving differences in efficacy. Future studies investigating the potential of combinatorial approaches may provide further insights into optimizing the therapeutic outcomes for patients with heart failure.

26 March 2025 in eLife
Verified
Journal Article
Open access
GHGabriel O Heckerman
Gabriel O Heckerman
ETEileen Tzng
Eileen Tzng
ACArely Campos-Melendez
Arely Campos-Melendez
CEChisomaga Ekwueme
Chisomaga Ekwueme
AMAdrienne Mueller
Adrienne Mueller
Background: Several fields have described low reproducibility of scientific research and poor accessibility in research reporting practices. Although previous reports have investigated accessible reporting practices that lead to reproducible research in other fields, to date, no study has explored the extent of accessible and reproducible research practices in cardiovascular science literature.Methods: To study accessibility and reproducibility in cardiovascular research reporting, we screened 639 randomly selected articles published in 2019 in three top cardiovascular science publications: Circulation, the European Heart Journal, and the Journal of the American College of Cardiology (JACC). Of those 639 articles, 393 were empirical research articles. We screened each paper for accessible and reproducible research practices using a set of accessibility criteria including protocol, materials, data, and analysis script availability, as well as accessibility of the publication itself. We also quantified the consistency of open research practices within and across cardiovascular study types and journal formats.Results: We identified that fewer than 2% of cardiovascular research publications provide sufficient resources (materials, methods, data, and analysis scripts) to fully reproduce their studies. Of the 639 articles screened, 393 were empirical research studies for which reproducibility could be assessed using our protocol, as opposed to commentaries or reviews. After calculating an accessibility score as a measure of the extent to which an article makes its resources available, we also showed that the level of accessibility varies across study types with a score of 0.08 for case studies or case series and 0.39 for clinical trials (p = 5.500E−5) and across journals (0.19 through 0.34, p = 1.230E−2). We further showed that there are significant differences in which study types share which resources.Conclusions: Although the degree to which reproducible reporting practices are present in publications varies significantly across journals and study types, current cardiovascular science reports frequently do not provide sufficient materials, protocols, data, or analysis information to reproduce a study. In the future, having higher standards of accessibility mandated by either journals or funding bodies will help increase the reproducibility of cardiovascular research.Funding: Authors Gabriel Heckerman, Arely Campos-Melendez, and Chisomaga Ekwueme were supported by an NIH R25 grant from the National Heart Lung and Blood Institute (R25HL147666). Eileen Tzng was supported by an AHA Institutional Training Award fellowship (18UFEL33960207).

30 May 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
ETEileen Tzng
Eileen Tzng
NBNathan Bayardo
Nathan Bayardo
GIGentaro Ikeda
Gentaro Ikeda
HTHiroyuki Takashima
Hiroyuki Takashima
JLJennifer Lyons
Jennifer Lyons
PYPhillip Yang
Phillip Yang
Background: Transplantation of mesenchymal stem cells or induced pluripotent stem cell derived cardiomyocytes improve heart function after myocardial infarction in pre-clinical models. Exosomes are extracellular vesicles, 30-150nm in size, which regulate the paracrine signal of the stem cells. We investigated the functional outcomes and biological effects of exosomes from pure populations of human bone marrow derived mesenchymal stem cells (MSCs) and induced pluripotent stem cell derived cardiomyocytes (iCMs) in a porcine acute myocardial infarction model. Methods: Yorkshire swine were subject to proximal left anterior descending artery occlusion with a catheter balloon for 1 hour for ischemia-reperfusion injury. Ten 500ul injections containing 5 x 10 11 exosomes isolated from the tissue culture media of iCMs or MSCs were delivered transendocardially into the peri-infarct region. Cardiac function was assessed by magnetic resonance imaging (MRI). Multi-omic analyses were performed in the ex vivo swine peri-infarct specimen to delineate the mechanism of action. Results: Cardiac MRI at weeks 2 and 4 showed significant improvement in heart function in iCM-derived exosomes while MSC-derived exosomes showed a trend towards improvement. A comparative analysis of transcriptomic sequencing of the porcine peri-infarct tissue and Next Generation Sequencing of the exosome cargo confirmed the dual mechanism of action. The marked improvements seen in cardiac function are conferred by miRNA carried by the exosomes, particularly by cardioprotective reduction in metabolism during acute myocardial injury while promoting concurrent cardiomyocyte cell cycle re-entry and proliferation. Conclusions: Significant reduction in myocardial metabolism and increase in proliferation signal pathways were found in both exosome treatment groups; however, distinct sets of microRNAs were found to underlie the mechanism of action in each population of exosomes.